ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,906Medicare Part D Prescriptions Filled, Including Refills

Rank: 311 out of 680

$453K Total Retail Price of All Prescriptions

Rank: 310 out of 680

375 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

8% of this provider’s 375 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 6,572 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 239 199 1 6
METFORMIN HCL 231 168 2 8
SIMVASTATIN 220 176 3 3
AMLODIPINE BESYLATE 218 200 4 1
OMEPRAZOLE 213 124 5 7
POTASSIUM CHLORIDE 149 143 6 14
CITALOPRAM HBR 138 131 7 22
LEVOTHYROXINE SODIUM 131 113 8 2
FLUTICASONE PROPIONATE 123 89 9 41
CYMBALTA 118 94 10 46
DONEPEZIL HCL 117 117 11 27
METOPROLOL TARTRATE 115 98 12 12
NEXIUM 114 96 13 16
WARFARIN SODIUM 105 94 14 20
BENAZEPRIL HCL 104 91 15 40
HYDROCHLOROTHIAZIDE 100 80 16 9
MELOXICAM 99 76 17 24
PRAVASTATIN SODIUM 96 82 18 10
GABAPENTIN 94 76 19 15
ISOSORBIDE MONONITRATE ER 94 88 19 59
TRAZODONE HCL 93 83 21 48
GLIMEPIRIDE 89 53 22 29
CARVEDILOL 81 75 23 23
ENALAPRIL MALEATE 80 74 24 65
POLYETHYLENE GLYCOL 3350 79 61 25 62
SPIRIVA 77 67 26 70
CLOPIDOGREL 76 70 27 26
HYDROCODONE-ACETAMINOPHEN 72 60 S3 28 4
RAMIPRIL 69 59 29 69
CLONIDINE HCL 66 36 30 36
NAMENDA 63 63 31 35
DIOVAN 63 53 31 31
TAMSULOSIN HCL 61 61 33 34
SYNTHROID 59 59 34 38
LOVASTATIN 58 58 35 44
QUETIAPINE FUMARATE 56 37 36 64
PLAVIX 55 46 37 39
CIPROFLOXACIN HCL 55 47 37 57
PREDNISONE 53 46 39 50
ATORVASTATIN CALCIUM 52 41 40 11
ZETIA 51 50 41 87
SINGULAIR 51 24 41 91
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 20, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.